
Meet Our Team
Management
J. Michael Redmond
President & CEO
Mr. Redmond has over 35 years commercial experience in medical device companies. Mr. Redmond held various sales and marketing positions at Abbott Laboratories, a multi-billion-dollar healthcare company. Mr. Redmond then went on to become the Director of Marketing and Business Development at KMC Systems Inc., now a leading private label developer and manufacturer of medical devices and instrumentation. Mr. Redmond helped grow the company from early stage to over $50M in revenue. KMC was sold to Elbit systems. Mr. Redmond then joined Bioject Inc as its VP of Sales and Marketing. Bioject was a medical device company specializing in unique drug delivery technologies. Mr. Redmond helped raise over $15M in capital, entered several licensing and distribution deals with major biotech and pharmaceutical companies growing the market cap of the company from under $10M to over $400M. Mr. Redmond has been CEO of Odyssey Health, Inc. since 2018.
Christine M. Farrell
Chief Financial Officer & Secretary
Christine M. Farrell joined Odyssey in April 2019 as a financial consultant serving as our Controller and Secretary and became Chief Financial Officer and Secretary in January 2021. From February 1997 to 2014, Ms. Farrell was Vice President of Finance for Bioject Medical Technologies Inc., a medical device company specializing in unique drug delivery technologies. Prior to joining Bioject, Ms. Farrell held accounting and financial management positions with Spar-Tek Industries, a manufacturer of high quality and cutting-edge technology for the plywood industry, and Action Machinery, a seller of new and used robotic machine tools and equipment. Ms. Farrell holds a B.A. degree in Accounting from the University of Washington and an M.B.A. from Willamette University in Salem, Oregon.
Jacob Vanlandingham
Executive VP of Drug Development
Dr. VanLandingham has a Ph.D. in Molecular Neuroscience from Florida State University. His postdoctoral training was in Behavioral Neuroscience within the Emergency Medicine Department at Emory University. Prior to his graduate training he worked as a Physical Therapist treating children with brain disorders. At Emory University he served as the Assistant Lab Director for the Brain Research Lab in the Department of Emergency Medicine. Dr. VanLandingham has over 20 years of research experience in brain injury and neurosteroid and enantiomer mechanisms of action. Prior to his Ph.D. work he was a Physical Therapist and cared for brain-injured children for 3-years. Dr. VanLandingham was one of the Year 1-2 Course Directors for 9-years at the Florida State University College of Medicine. He has been honored with multiple teaching, grant and patent awards. He has overseen his own clinic for treating concussed patients and developed rehab techniques to improve return to activity. In 2012 Dr. VanLandingham began developing the first drug to treat concussion acutely. Odyssey acquired the technology and Dr. VanLandingham was brought on to lead the R and D efforts. Dr. VanLandingham has been part of grants for brain injury research as well as review committees for such work. He is a survivor of a severe traumatic brain injury that left him with amnesia for 2-years.
Board of Directors
Jerome H. Casey
Jerome H. Casey has been a Director since September 2019. Mr. Casey has been a leader in the life science industry for over 30 years. Mr. Casey served as a senior executive at Genzyme Corporation, a biotechnology company, from 1989 to 2011. Mr. Casey was the driver behind Genzyme’s commercial success in the diagnostics arena, building a $175 million business which Genzyme sold to Japan-based Sekisui Chemical in 2011. Mr. Casey then became the President and COO of the new entity, Sekisui Diagnostics, LLC, until the end of 2014. While President and COO, Mr. Casey established the strategic direction for the company; led the global organization, including the commercial, operations, research and development, finance, human resources, and legal functions; and achieved the annual and long-term financial objectives of the business. Since 2015, Mr. Casey has been actively involved in several life sciences ventures, both as an advisor and an investor, while serving on multiple Boards. Mr. Casey holds an M.B.A. degree in Finance and a B.A. degree in Political Science from the University of Connecticut.
Jeffrey Conroy
Jeffrey Conroy has been a Director since August 2019. Mr. Conroy is an operating and business development executive with over 30 years in the life science industry across therapeutics and medical devices. Mr. Conroy has served as the Chairman and CEO of Embody, a DARPA-funded medical device company developing regenerative implants for tendon and ligament repair, from July 2015 to present. From 2012 to 2019, he served as the Head of Corporate Development for Especificos Stendhal S.A. de C.V., a Latin American specialty pharmaceutical company. Mr. Conroy is also currently the Managing Director of Windward Investments, where he structures licensing partnerships for life science companies. Mr. Conroy is an independent director of Cingulate Therapeutics, a CNS company developing ADHD therapeutics. Mr. Conroy holds a B.S. degree in Business Administration from Providence College.
John P. Gandolfo
John P. Gandolfo has been a Director since October 2019. Mr. Gandolfo has approximately 33 years of experience as a Chief Financial Officer (“CFO”) of multiple rapidly growing private and publicly held companies with a primary focus in the life sciences, healthcare and medical device areas. Mr. Gandolfo has had direct responsibility over capital raising, including five public offerings, financial management, mergers and acquisition transactions and SEC reporting throughout his professional career. Mr. Gandolfo serves as CFO of Eyenovia, Inc., a late-stage ophthalmic biopharmaceutical company, from January 2018 to present. Prior to this, Mr. Gandolfo was CFO of Xtant Medical Holdings, Inc., a biologics company, from July 2010 through September 2017. Prior to this, he served as the CFO for Progenitor Cell Therapy LLC from January 2009 to June 2010 and, before that, as CFO of Power Medical Interventions, Inc. from January 2007 to January 2009. Mr. Gandolfo was the CFO of Bioject Medical Technologies, Inc. prior to this. He was also the CFO of Capital Access Network, Inc., from 2000 through September 2001, and Xceed, Inc. from 1999 to 2000. From 1994 to 1999, Mr. Gandolfo was CFO and COO of Impath, Inc. From 1987 through 1994, he was CFO of Medical Resources, Inc. Mr. Gandolfo received his B.A. degree in Business Administration from Rutgers University. Mr. Gandolfo is currently a member of the Board of Directors of Electrocore, Inc. and sits on their audit committee.
Ricky W. Richardson
Ricky W. Richardson has been a Director since May 2021. Mr. Richardson has over 30 years of experience as a global operations and quality leader. He possesses strong operations and quality experience that includes change management, multi-plant operations, financial acumen, supply chain/vendor management, strategic business development, start-up planning and execution, new product introductions, and lean deployment. His most recent positions included Corporate Director of Danaher Business Systems (“DBS”). From February 2008 to July 2011, Mr. Richardson was Director of Operations for Continuous Improvement for Stryker Orthopaedics, a multi-billion dollar global manufacturer of Orthopaedics. Prior to this, Mr. Richardson held various positions at Bioject Medical Technologies, Inc., Baxter Healthcare, and Texas Instruments. From 1984 to 1987, he was a Lieutenant, Field Artillery, with the U.S. Army. He holds a B.S. degree in Engineering from the U.S. Military Academy, West Point, NY.
Scientific Advisory Board
James P. Kelly, MA, MD, FAAN, FANA
Dr. Kelly is the Executive Director of the Marcus Institute for Brain Health (MIBH) and Professor of Neurology at the University of Colorado Anschutz Medical Campus in Aurora, CO. The MIBH is a specialized treatment program funded by the Marcus Foundation to care for US military Veterans with persistent symptoms of TBI. He is also National Director of the Gary Sinise Foundation Avalon Network TBI Medical Programs for which the MIBH serves as the clinical coordinating center.
His immediate past position was Director of the National Intrepid Center of Excellence (NICoE) at Walter Reed National Military Medical Center in Bethesda, MD. As its founding Director, he led the creation of an innovative interdisciplinary team of healthcare professionals who blended high-tech diagnosis and treatment with complementary and alternative medical interventions in a holistic, integrative approach to the care of US military personnel with the complex combination of TBI and psychological conditions such as post-traumatic stress, depression and anxiety. In this role, Dr. Kelly was frequently called upon by leaders of the Military Health System in the Pentagon, the US Congress, the Department of Veterans Affairs and numerous military facilities in the continental US and abroad. He twice traveled to Afghanistan to advise and assist at military hospital programs and forward operating base medical units.
Dallas C. Hack, MD, MPH, FACMPH, COL, US Army
Dr. Dallas C. Hack graduated from Loma Linda University School of Medicine in 1976. After a rotating internship in Anesthesiology and a fellowship in Cardiology and Biomathematics, he worked in General Practice and Biomedical Engineering for 9 years, serving as Vice President of Engineering for a number of biomedical companies. He entered active duty in September 1987, to accept a position in clinical research at the US Army Medical Research Institute of Infectious Diseases (USAMRIID) and completed a residency in General Preventive Medicine in 1995. He also has a MPH from Johns Hopkins University, a MSS from the US Army War College, a CPE from the Certifying Commission in Medical Management, and is a Fellow of the American College of Military Public Health.
After assignments at Fort Detrick, Fort Knox, and SHAPE, Belgium, COL(R) Hack then served as the Command Surgeon for the US Army Central Command-Kuwait from 2001 to 2002 (arriving in theater the day before 9/11) where he directed medical care for the US military in Kuwait, Saudi Arabia, and Qatar. He also served as Deputy Commander for Clinical Services for 3rd MEDCOM, assisting with planning medical support for Operation Enduring Freedom and providing clinical oversight over medical operations in Afghanistan and Pakistan.
From 2008 to 2014, COL(R) Hack was the Director of the Combat Casualty Care Research Program (CCCRP) where he led trauma research across the Department of Defense, with a focus on Traumatic Brain Injury (TBI). He oversaw 650 TBI research projects and over $850 million in federal funds for TBI research. COL(R) Hack helped establish the 2013 National Research Action Plan on TBI and PTSD, the Chronic Effects of Neurotrauma Consortium, and the NCAA-DoD Grand Alliance.
Military Advisory Board
James Linder
Jim Linder is a recognized leader in the world of Special Operations and Intelligence organizations as a high performing and skilled strategist. A US General Officer with over three decades of direct command leadership around the globe.
Originally from South Carolina, Jim graduated from Clemson University as a Distinguished Military Graduate. His service has taken him to over 71 countries across Europe, into South East Asia, throughout Africa and the Middle East, and Central and South America.
As a General Officer, he created new cutting-edge capabilities and accelerated the growth of highly skilled Afghan Special Forces. He also led and directed all US special operations across the African continent, while interacting with US interagency and African leaders to achieve US national security goals. He adeptly applied new ideas as commandant of the Army’s premier Center of Excellence for selecting and training Special Operations Forces and was the commander of all US and NATO special operations forces in combat in Afghanistan during a critical period of transition. Most recently, he achieved value-driven results managing a complex and agile organization of 80k persons with a $13.4B government operating budget as the Chief of Staff for US Special Operations Command.
Major General (retired) Linder is currently the President of Tenax Aerospace and has master’s degrees in International Relations from Webster University and National Security and Strategic Studies from the US Naval War College.
Francis Beaudette
Over the course of his 32-year career in Army and Joint assignments, the majority of it as a Green Beret, Francis “Fran” M. Beaudette served with high performing organizations at varying levels, from a 12-man Special Forces ‘A-team’ to the 36,000-Soldier and Civilian US Army Special Operations Command.
His recent assignments were Deputy Commanding General of the 1st Armored Division, Assistant Commanding General of JSOC, CG of 1st Special Forces Command and Commanding General of the US Army Special Operations Command.
His operational assignments, totaling six years of deployed time, include the first Gulf War; comprehensive Africa experience to include noncombatant evacuation operations in Sierra Leone and the Congo; multiple peacekeeping operations in Kosovo; numerous deployments in Iraq, Afghanistan, the Philippines and Jordan, all during eras of war, turmoil or crisis.
Fran was a distinguished academic and military graduate from the Citadel and holds a MA in Military Arts and Science from the US Army Command & General Staff College and a MS in Strategic Studies from the US Army War College.
Paul Toolan
Lieutenant Colonel (LTC) Paul Toolan joined the Army as a Private in 1986. Over the course of more than three decades in uniform, he has risen through the ranks and completed every elite school in the US Army. He is a Special Forces Airborne Ranger and started his Special Forces career as a Detachment Commander in 3rd Special Forces Group at Fort Bragg. He has held nearly a dozen leadership positions in multiple Special Forces Groups, including Detachment Commander, Company Executive Officer, Battalion Operations Officer, Support Company Commander, Company Commander, Group Operations Officer, Group Executive Officer, Battalion Commander, Chief of the Special Forces Training Division, and the Director of Operations at 1st Special Forces Command. He has worked at the National Counter-Terrorism Center as a Special Forces advisor and worked as a Special Forces consultant in the United States Army Special Operations Commander’s Initiatives Group. He last duty assignment was the Deputy Commander of the 1st Special Warfare Training Group at Fort Bragg, North Carolina, where Green Berets are assessed, selected and trained.
Since retiring from military service, Paul has dedicated himself to helping Special Operators address the effects of life in Special Operations such as post-traumatic stress (PTS), traumatic brain injury (TBI) and Operator Syndrome (overstimulated sympathetic nervous system) by facilitating access to treatment innovations.
Timothy Szymanski
Vice Admiral (r) Szymanski has led and served in many Navy and Joint Special Operations assignments as a Navy Special Warfare Officer (SEAL) for over 36 years. He most recently served as the Deputy Commander for United States Special Operations Command (USSOCOM) after serving as the Commander of Naval Special Warfare (NSW). In both roles he was responsible for the manning, equipping, and training, and employment of Navy SEAL and joint special operations forces, of 11,000 and 73,000 uniformed and civilian personnel, respectively.
He has commanded a SEAL Team, Special Boat Team, a Squadron at a Special Mission Unit, and a Special Operations Joint Task Force. His recent assignments as a flag officer were Deputy Commander USSOCOM, Commander Naval Special Warfare Command, Assistant Commanding General Joint Special Operations Command and Deputy Commander of NATO Special Operations Component Command – Afghanistan. Szymanski attended the U.S. Naval Academy Preparatory School and graduated from the United States Naval Academy in 1985.
Keenly aware of the detrimental effects of invisible wounds on Force and Family Readiness, he established policy to cognitively baseline the entire Special Operations community as well as created initiatives to prevent, protect, recover, and enhance cognitive performance.
Sports Advisory Board
Abby Wambach
Abby Wambach was born in Rochester, NY and is a decorated American association football (soccer) player who was one of the sport’s leading forwards. She helped the U.S. Women’s National Team (USWNT) win two Olympic gold medals (2004 and 2012) and a World Cup (2015). In 2012 she was named Women’s Player of the Year by the Fédération Internationale de Football Association (FIFA). Wambach made her first appearance for the USWNT in 2001. Wambach started nine times for the USWNT in 2003, including all five U.S. matches in the FIFA Women’s World Cup, where the United States finished third. She was named U.S. Soccer’s Female Athlete of the Year, a feat she achieved again in 2004, 2007, 2010, 2011, and 2013. Abby is aware of the higher risk for female athletes to sustain a concussion. The consequences of repetitive concussion in this population concerns her deeply. As the leading international player in header goals in the history of the sport she worries about her own future brain health. She was a vocal leader in developing US Soccer rules that ban youth athletes 10 and under from heading the ball in games and practice.
Brett Favre
NFL legend Brett Favre attended the University of Southern Mississippi, and after a stellar college career, Favre was selected by the Atlanta Falcons in the 1991 NFL draft. Following his trade to the Green Bay Packers the next year, Favre began his legendary NFL career and led the franchise to victory in Super Bowl XXXI. Favre, an NFL ironman, started 299 consecutive games, a record that still stands today. Among his achievements, he recorded six 4,000 passing yard seasons; was named all NFC 6 times and elected to 11 pro bowl teams. When Favre retired from football after the 2010 season, he held the NFL records for passing attempts, completions, passing yards and touchdown passes. Favre was enshrined into the NFL Hall of Fame in 2016. Brett’s last play and the end of his iron-man streak was a concussion. He has many retired friends from the league who are struggling with mental health. Brett is an advocate for not playing tackle football until the age of 14 and is a big supporter of finding a treatment for concussion that can prevent our youth from being the next generation of players who may have to deal with conditions such as Chronic Traumatic Encephalopathy.
Kurt Warner
Kurt Warner's football career has proven to be of the more improbable rags-to-riches stories ever to come out of the sports world. Bypassed by the big Division I colleges, and at one point working the night shift stocking shelves at a supermarket so he could stay in football shape during the day, Warner, a 28-year-old back-up quarterback, catapulted to stardom in 1999. During his second full year in the NFL, he drove a high-powered St. Louis Rams offense to a Super Bowl victory and collected MVP honors along the way. Over the ensuing decade, Warner captained two other teams to the Super Bowl, registered another MVP season and threw for more than 200 career touchdowns. In 12 NFL seasons, Warner was selected to 4 Pro Bowl teams among his numerous accolades. He was enshrined in the NFL Hall of Fame in 2017. The challenges of traumatic brain injury hit very close to home for Kurt who has an adult son living with the aftermath. Kurt and his wife Brenda created the Treasure House in Scottsdale, AZ, a state-of-the-art facility for treating and caring for adult brain-injured patients.
Mark Rypien
Mark Rypien is a former professional football quarterback who has played for some of the best NFL teams as a Washington Redskin. Born in Alberta, Canada, Mark moved to the United States at the age of 3 and was an athletic kid. He was a star athlete in school, playing basketball, baseball, and football. Following his high school graduation, he chose football and enrolled into the Washington State University on a football scholarship. He was selected by the Washington Redskins in the 1986 NFL Draft. In his stellar NFL career, he appeared in 104 games and had 115 touchdowns with 88 interceptions and 18,473 passing yards. Mark Rypien has a multitude of achievements throughout his NFL career. He is a 2 time Super Bowl champion (XXII, XXVI), a Super Bowl MVP (XXVI) in addition to being elected to the Pro Bowl two times. Mark has struggled with mental health issues following the many concussions he experienced in his career. He is a strong advocate for finding a treatment for concussion to protect the brains’ of our youth.
David Ross
David Ross is an American professional baseball manager for the Chicago Cubs and former catcher for numerous teams in Major League Baseball (MLB). He played for 15 years in MLB. Ross played college baseball for Auburn University and the University of Florida and participated in two College World Series. He started his major league career playing for the Los Angeles Dodgers in 2002 and also played for the Pittsburgh Pirates, San Diego Padres, Cincinnati Reds, Boston Red Sox, Atlanta Braves, and Chicago Cubs. Ross had two World Series wins with the Boston Red Sox in 2013 and the Chicago Cubs in 2016. The Cubs named him their manager prior to the 2020 season. David experienced many concussions as a catcher and missed many games due to Post-Concussion Syndrome in his career.
Steve “Mooch” Mariucci
Mariucci is a former National Football League head coach. He coached for the San Francisco 49ers and the Detroit Lions. Mariucci was born and raised in Iron Mountain, Michigan, and was a three-time All-America (Division II) quarterback at Northern Michigan University (NMU) in Marquette. On NFL Sundays, Steve Mariucci appears on NFL Network's Emmy-nominated NFL GameDay Morning, joining fellow analysts to discuss the upcoming games. Additionally, Mariucci provides on-location analysis for NFL Network's coverage of the Super Bowl, NFL Scouting Combine and NFL Draft. He is a member of the NFL Player Safety Advisory Panel that has concussion prevention fist and foremost on their minds.